Improved adherence with Medicines Use Review service in Slovenia: a randomized controlled trial

Nabergoj Makovec, Urška; Locatelli, Igor; Kos, Mitja

doi:10.1186/s12913-021-06223-8

BMC Health Services Research

Table 3 Multiple linear regression models to predict difference in adherence between visits (V2-V1) for total ©MMAS-8 score, intentional non-adherence ©MMAS-8 score and unintentional non-adherence ©MMAS-8 score (N = 138)

From: Improved adherence with Medicines Use Review service in Slovenia: a randomized controlled trial

	Total			Intentional			Unintentional
	B	95% CI for B	p value	B	95% CI for B	p value	B	95% CI for B	p value
Constant	−1.059	−3.05 – 0.93	0.294	−0.335	−1.84 – 1.17	0.661	−0.724	−1.84 - 0.39	0.201
*MUR effect for low adherent patients*	1.201	0.16–2.25	0.025	0.841	0.05–1.63	0.038	0.360	−0.23 - 0.95	0.226
*Baseline adherence*^a	−0.973	−1.68 - -0.26	0.008	−0.540	−1.08 - -0.00	0.049	−0.433	−0.83 - -0.04	0.033
*Interaction* [MUR effect baseline adherence]*	−1.229	−2.37 - -0.09	0.035	−0.812	−1.68 – 0.05	0.066	−0.416	−1.06 - 0.22	0.200
*Self-reported current health status*^b [1,2,3,4,5]	0.342	0.03–0.65	0.032	0.290	0.05–0.53	0.016	0.052	−0.12 - 0.23	0.558
*Gender* (male vs. female)	0.063	−0.39 – 0.52	0.785	−0.065	−0.41 – 0.28	0.712	0.128	−0.13 - 0.38	0.325
*Age^b [years]*	0.026	−0.002 – 0.05	0.068	0.006	−0.02 – 0.03	0.587	0.020	0.00–0.04	0.012
*Education*^b [1,2,3,4]	−0.194	− 0.44 – 0.05	0.114	0.007	−0.18 – 0.19	0.936	−0.201	− 0.34 - -0.07	0.004
*Employment status* (retired vs. non-retired)	−0.403	−1.18 – 0.37	0.305	−0.198	−0.78 – 0.39	0.506	−0.206	− 0.64 - 0.23	0.349
*Number of Rx medicines for regular use*^b	−0.005	−0.10 – 0.09	0.918	0.007	−0.07 – 0.08	0.844	−0.012	−0.07 - 0.04	0.653
*Different pharmaceutical forms*^c	0.243	−0.20 – 0.69	0.280	0.065	−0.27 – 0.40	0.704	0.179	−0.07 - 0.43	0.157
*(Co)paying for medicines* (no vs. yes)	−0.266	−0.68 – 0.15	0.202	−0.391	− 0.70 - -0.08	0.014	0.125	−0.11 - 0.36	0.284
Model summary	N = 138; R² = 0,238; p < 0,001			N = 138; R² = 0,176; p = 0,009			N = 138; R2 = 0,216; p < 0,001

^a baseline moderate and high versus baseline low adherence in control group
^b included as scale variable
^c different pharmaceutical forms vs. only tablets and capsules

Back to article page

ISSN: 1472-6963

Contact us

General enquiries: journalsubmissions@springernature.com